Herein, despite miR-223-3p expression being up-regulated in LPS primed and Aβ42-stimulated PBMC of AD patients, no significant reduction was observed in NLRP3 mRNA expression and this resulted in higher caspase-1 cleavage, IL-1β and IL-18 release. Here, NLRP3 is linked to Alzheimer disease.